ENTERIC FEVER
John O Dickson
1st August, 2018
OUTLINE
 Epidemiology
 Pathogenesis
 Clinical features
 Investigation
 Management
 Complications
 Prevention
 Considerations
EPIDERMIOLOGY
• Organism – Salmonella typhi
• Infects only humans
• Patients excrete organisms in respiratory
secretions, Urine and Feces
• Convalescent and Chronic carrier often exist in
adult. (“Typhoid Mary” – Mary Mallon)
EPIDERMIOLOGY (Cont’d)
• According to the World Health Organization 2004
census, approximately 21.6 million cases occur per
year worldwide, mostly in Asia, Africa, and Latin
America, with 200,000 fatalities.
• Long survival of S. typhi in food facilitates transmission
• Transmission is usually through faeco-oral route
• Typhoid is endemic in Nigeria and it is a major cause
of morbidity and mortality for all ages
Salmonella Typhi
• Non-lactose fermenting, gram-negative bacillus and
has antigenic markers designated
– ‘O’ or somatic (cell wall) antigen
– ‘H’ or flagella antigen
– ‘V’ or virulence (or capsular) antigen .
• These antigen are also shared by other salmonella and
some coliforms, Hence in terms of diagnosis problems
can arise, causing false positive diagnosis.
PATHOGENESIS
• Following Ingestion, there is transient
bacteramia. This is followed by multiplication of
the bacterial in the reticulo-endothelial system
(eg. the Peyer’s patches), liver, and biliary
tracts.
• In the lymph nodes, the bacilli induce
hypertrophy, then ulceration and then necrosis.
PATHOGENESIS cont’d.....
• After incubation period of 7 -21 days, the
organism will invade the blood steam. The
larger the infecting dose of bacilli, the shorter
the incubation period
• Virulent typhoid bacilli inhibit the post
phagocytic oxidative metabolism of neutrophil,
unlike non-virulent typhoid strain and others
bacteria
PATHOGENESIS contd...........
• Having affinity for Peyer’s patches and the intestinal
lymphoid follicles.
• They may undergo necrosis, and ulcerations leading
to intestinal perforations or haemorrhage.
• This secondary septicaemia is usually prolonged
with the gall bladder being particularly susceptible.
CLINICAL FEATURES
• Varied features
• May mimic other illnesses
• High Index of suspicion
• High fever usually present, may be low grade or
absent in children that are malnourished
• Gastrointestinal symptoms
– anorexia, vomiting
– Abdominal pain, diarrhoea, constipation
CLINICAL FEATURES contd.........
– Presentation as perforation or haemorrhage.
– Jaundice, Hepatosplenomegaly
• Respiratory symptoms – e.g. bronchopneumonia
• CNS symptoms.
– lethargy, coma, convulsion, psychosis
• Macula-papular rash not seen in pigmented skins,
especially in blacks
INVESTIGATIONS
• 1. Blood culture
– isolation of salmonella typhi – Bone marrow
aspirate if antibiotics has already been taken.
Excluding relapsed blood culture not positive
after 2 weeks
• 2. Stool culture:
– positive from 2nd week in highly febrile patient
• 3. Widal test (lacks specificity and sensitivity)
– An agglutination test for antibodies to the ‘O’
and ‘H’ antigens.
INVESTIGATION contd........
• Useful if the range in the local population is known.
• Paired sera with a rising or falling titer is more useful
than a single determination
• Although titer of ‘O’ 1:500 or above usually
significant.
• Newer tests include immunoelectrophoresis
available in developed countries.
MANAGEMENT
• Adequate fluid and electrolyte balance
necessary
• Antipyretics and measures necessary
• Patient should be treated for 10-14day
• Cases with complication treat for 21 days.
MANAGEMENT contd...
Antibiotics therapy
• Chloramphenicol (1948-1970s) – antibiotic of choice in dose
of 50-100m/kg/24hrs in children and 25mg/kg/24hrs in
Neonates giving intravenously 6hrly
(NB: Relapse occur with chloramphenicol frequently and
associated with carrier states).
• Ampicillin or amoxycillin at 100mg/kg/24hrs
• Septrin (1980s)i.e. trimethoprin/sulphamethoxazole
– This has slower clinical response but no relapse or
chronicity
• OTHER MGT.
– Steroid can be use in cases of very ill patient who are toxic
looking.
– Surgical intervention reduces morbidity and mortality in
case of perforation or haemorrhage.
Antibiotics therapy Cont’d
• Fluoroquinolones – are the best drugs for treating
Typhoid (e.g ciprofloxacin).
• Alternatives include: Third generation
Cephalosporins (Ceftriaxone) and Azithromycin.
• OTHER MGT.
– Steroid can be use in cases of very ill patient
who are toxic looking. Hydrocortisone - 3mg/kg
over 30min, then 1mg/kg QDS X 8doses
– Surgical intervention reduces morbidity and
mortality in case of perforation or haemorrhage.
COMPLICATIONS
• Neuropsychiatric – delirium, irrational behavior,
convulsions, coma.
• Intestinal hemorrhage and perforation.
• Septic shock.
• Salmonella osteomyelitis.
• Typhoidal acute renal failure.
• Toxic myocarditis.
• DIC
CARRIER STATES
• NB: Convalescent carriers excrete the bacteria for periods
up to 3 months
• Patients still excreting past 3 months and up to 1 year meet
the definition of chronic carriers.
• Faecal carriage is more in those with gallbladder disease,
while urinary carriage is more in those with urinary
schistosomiasis and nephrolithiasis
• Gall bladder infection: 80% cured with cholecystectomy
with or without antibiotics.
• High dose ampicillin with probenecide for 4-6 wks also
effective.
PREVENTION
• Measures for individual protection are to kill S. typhi in
boiling water before drinking, iodination or
chlorination, care with uncooked or reheated food, and
immunization.
• Patients and convalescents with typhoid should be
advised to wash their hands after using the toilet and
before preparing food and to use separate towels.
• Primordial and primary prevention at the level of
government and community + Vaccination
THANKS FOR LISTENING!

Enteric Fever

  • 1.
    ENTERIC FEVER John ODickson 1st August, 2018
  • 2.
    OUTLINE  Epidemiology  Pathogenesis Clinical features  Investigation  Management  Complications  Prevention  Considerations
  • 3.
    EPIDERMIOLOGY • Organism –Salmonella typhi • Infects only humans • Patients excrete organisms in respiratory secretions, Urine and Feces • Convalescent and Chronic carrier often exist in adult. (“Typhoid Mary” – Mary Mallon)
  • 4.
    EPIDERMIOLOGY (Cont’d) • Accordingto the World Health Organization 2004 census, approximately 21.6 million cases occur per year worldwide, mostly in Asia, Africa, and Latin America, with 200,000 fatalities. • Long survival of S. typhi in food facilitates transmission • Transmission is usually through faeco-oral route • Typhoid is endemic in Nigeria and it is a major cause of morbidity and mortality for all ages
  • 5.
    Salmonella Typhi • Non-lactosefermenting, gram-negative bacillus and has antigenic markers designated – ‘O’ or somatic (cell wall) antigen – ‘H’ or flagella antigen – ‘V’ or virulence (or capsular) antigen . • These antigen are also shared by other salmonella and some coliforms, Hence in terms of diagnosis problems can arise, causing false positive diagnosis.
  • 6.
    PATHOGENESIS • Following Ingestion,there is transient bacteramia. This is followed by multiplication of the bacterial in the reticulo-endothelial system (eg. the Peyer’s patches), liver, and biliary tracts. • In the lymph nodes, the bacilli induce hypertrophy, then ulceration and then necrosis.
  • 7.
    PATHOGENESIS cont’d..... • Afterincubation period of 7 -21 days, the organism will invade the blood steam. The larger the infecting dose of bacilli, the shorter the incubation period • Virulent typhoid bacilli inhibit the post phagocytic oxidative metabolism of neutrophil, unlike non-virulent typhoid strain and others bacteria
  • 8.
    PATHOGENESIS contd........... • Havingaffinity for Peyer’s patches and the intestinal lymphoid follicles. • They may undergo necrosis, and ulcerations leading to intestinal perforations or haemorrhage. • This secondary septicaemia is usually prolonged with the gall bladder being particularly susceptible.
  • 9.
    CLINICAL FEATURES • Variedfeatures • May mimic other illnesses • High Index of suspicion • High fever usually present, may be low grade or absent in children that are malnourished • Gastrointestinal symptoms – anorexia, vomiting – Abdominal pain, diarrhoea, constipation
  • 10.
    CLINICAL FEATURES contd......... –Presentation as perforation or haemorrhage. – Jaundice, Hepatosplenomegaly • Respiratory symptoms – e.g. bronchopneumonia • CNS symptoms. – lethargy, coma, convulsion, psychosis • Macula-papular rash not seen in pigmented skins, especially in blacks
  • 11.
    INVESTIGATIONS • 1. Bloodculture – isolation of salmonella typhi – Bone marrow aspirate if antibiotics has already been taken. Excluding relapsed blood culture not positive after 2 weeks • 2. Stool culture: – positive from 2nd week in highly febrile patient • 3. Widal test (lacks specificity and sensitivity) – An agglutination test for antibodies to the ‘O’ and ‘H’ antigens.
  • 12.
    INVESTIGATION contd........ • Usefulif the range in the local population is known. • Paired sera with a rising or falling titer is more useful than a single determination • Although titer of ‘O’ 1:500 or above usually significant. • Newer tests include immunoelectrophoresis available in developed countries.
  • 13.
    MANAGEMENT • Adequate fluidand electrolyte balance necessary • Antipyretics and measures necessary • Patient should be treated for 10-14day • Cases with complication treat for 21 days.
  • 14.
    MANAGEMENT contd... Antibiotics therapy •Chloramphenicol (1948-1970s) – antibiotic of choice in dose of 50-100m/kg/24hrs in children and 25mg/kg/24hrs in Neonates giving intravenously 6hrly (NB: Relapse occur with chloramphenicol frequently and associated with carrier states). • Ampicillin or amoxycillin at 100mg/kg/24hrs • Septrin (1980s)i.e. trimethoprin/sulphamethoxazole – This has slower clinical response but no relapse or chronicity • OTHER MGT. – Steroid can be use in cases of very ill patient who are toxic looking. – Surgical intervention reduces morbidity and mortality in case of perforation or haemorrhage.
  • 15.
    Antibiotics therapy Cont’d •Fluoroquinolones – are the best drugs for treating Typhoid (e.g ciprofloxacin). • Alternatives include: Third generation Cephalosporins (Ceftriaxone) and Azithromycin. • OTHER MGT. – Steroid can be use in cases of very ill patient who are toxic looking. Hydrocortisone - 3mg/kg over 30min, then 1mg/kg QDS X 8doses – Surgical intervention reduces morbidity and mortality in case of perforation or haemorrhage.
  • 16.
    COMPLICATIONS • Neuropsychiatric –delirium, irrational behavior, convulsions, coma. • Intestinal hemorrhage and perforation. • Septic shock. • Salmonella osteomyelitis. • Typhoidal acute renal failure. • Toxic myocarditis. • DIC
  • 17.
    CARRIER STATES • NB:Convalescent carriers excrete the bacteria for periods up to 3 months • Patients still excreting past 3 months and up to 1 year meet the definition of chronic carriers. • Faecal carriage is more in those with gallbladder disease, while urinary carriage is more in those with urinary schistosomiasis and nephrolithiasis • Gall bladder infection: 80% cured with cholecystectomy with or without antibiotics. • High dose ampicillin with probenecide for 4-6 wks also effective.
  • 18.
    PREVENTION • Measures forindividual protection are to kill S. typhi in boiling water before drinking, iodination or chlorination, care with uncooked or reheated food, and immunization. • Patients and convalescents with typhoid should be advised to wash their hands after using the toilet and before preparing food and to use separate towels. • Primordial and primary prevention at the level of government and community + Vaccination
  • 19.